siRNA, Anti-NIPBL, 2'-F/2'-OMe/LNA/Ribo/Backbone-modified(CAT#: SIRGT74015WQ-LNA)
The product SIRGT74015WQ-LNA is a type of small interfering RNA (siRNA) that targets NIPBL gene and regulates the expression of gene. The siRNA interferes with the expression of NIPBL gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_133433.3 |
| Alternative Names | CDLS; CDLS1; IDN3; IDN3-B; Scc2 |
| Related Diseases | Cornelia De Lange Syndrome 1 |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT71015WQ-2OMe | NIPBL | Human | 2ʹ-O-methyl (2'-OMe) | ||
| SIRGT72015WQ-2F | NIPBL | Human | 2ʹ-deoxy-2ʹ-fluoro (2'-F) | ||
| SIRGT71015WQ-RB | NIPBL | Human | Ribo-modified | ||
| SIRGT72015WQ-BB | NIPBL | Human | Backbone-modified |
